_(2).png)
Organ-on-chips (OOCs) are an upcoming class of therapeutic testing models that have garnered significant attention of pharmaceutical companies, and academic / research institutions across the globe.
More than 70 organ-on-a-chip technologies and models have been launched / approved or are currently under development; notably, the market landscape features the presence of both established players and new entrants. The global organs on chips market size is estimated to be USD 77 million in 2024 and is projected to reach USD 944 million by 2035.The market is anticipated to grow at a CAGR of 25.6%, during the forecast period till 2035.
During our research, we were able to identify more than 25 prominent players that offer organ-on-a-chip technologies and models. It is worth mentioning that more than 55% of the technologies and model providers are headquartered in Europe. This can be attributed to the fact that the region has shown significant growth in the domain supported by the increasing collaborations between companies and government institutes along with the increasing research efforts and fundings.
97% of the technologies and models offer drug discovery / toxicity testing as their area of application. It is also worth mentioning that liver based models emerged as the most prominent single organ based model (33%), followed by lung based models (29%).
Further, considering the active engagement of industry players in this domain, the market for organ-on-a-chip technologies and models is likely to grow in the foreseen future.
Presently, 25 players (established players as well as start-ups) claim to provide organ-on-a-chip and plates; more than 60% of these firms have been established post-2013
More than 20 prominent players that offer organ-on-chips and plates. It is worth mentioning that more than 55% of the chips and plate providers are headquartered in Europe, of these, most of the players are headquartered in France (29%). This can be attributed to the fact that significant investments in research combined with strategic collaborations between industry and non-industry players is accelerating biofabrication advancements, propelling the growth of the market.
94% of the chips and plates are made of polymer, of which, 50% of the products are made of polydimethylsiloxane (PDMS). This can be attributed to the fact that PDMS provides gas permeability, flexibility and transparency to the chip base, which makes it easy and cost efficient to manufacture chips and plates. Further, considering the active engagement of industry players in this domain, the market for organ-on-chips and plates is likely to grow in the foreseen future.
Research Methodology
Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Organs-on-Chips Market.
Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/organ-on-a-chip-market.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.
Contact:
Roots Analysis
+1 (415) 800 3415
Comments